Total Payments
$252,898
2024 Payments
$46,678
Companies
13
Transactions
137
Medicare Patients
14,279
Medicare Billing
$1.4M
Payment Breakdown by Category
Other$232,794 (92.1%)
Travel$14,218 (5.6%)
Consulting$3,590 (1.4%)
Food & Beverage$2,296 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $232,769 | 41 | 92.0% |
| Travel and Lodging | $14,218 | 52 | 5.6% |
| Consulting Fee | $3,590 | 2 | 1.4% |
| Food and Beverage | $2,296 | 40 | 0.9% |
| Entertainment | $25.00 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $251,798 | 119 | $0 (2024) |
| Medicure Pharma Inc. | $594.70 | 2 | $0 (2017) |
| Kiniksa Pharmaceuticals, Ltd. | $105.44 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $91.37 | 2 | $0 (2018) |
| Boston Scientific Corporation | $73.94 | 2 | $0 (2024) |
| Amgen Inc. | $60.32 | 2 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $35.73 | 2 | $0 (2017) |
| Cardiovascular Systems Inc. | $34.45 | 1 | $0 (2022) |
| Invuity, Inc. | $25.00 | 2 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $23.28 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46,678 | 17 | GENZYME CORPORATION ($46,664) |
| 2023 | $30,339 | 23 | GENZYME CORPORATION ($30,210) |
| 2022 | $26,705 | 10 | GENZYME CORPORATION ($26,670) |
| 2021 | $14,264 | 6 | GENZYME CORPORATION ($14,244) |
| 2020 | $14,993 | 10 | GENZYME CORPORATION ($14,933) |
| 2019 | $74,676 | 40 | GENZYME CORPORATION ($74,676) |
| 2018 | $36,268 | 18 | GENZYME CORPORATION ($36,139) |
| 2017 | $8,975 | 13 | GENZYME CORPORATION ($8,262) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,259.00 | General |
| Category: Genetic Disease | ||||||
| 09/04/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $726.96 | General |
| Category: Genetic Disease | ||||||
| 09/04/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $213.21 | General |
| Category: Genetic Disease | ||||||
| 09/04/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $140.38 | General |
| Category: Genetic Disease | ||||||
| 09/04/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $58.15 | General |
| Category: Genetic Disease | ||||||
| 09/04/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $13.00 | General |
| Category: Genetic Disease | ||||||
| 06/21/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,420.00 | General |
| Category: Genetic Disease | ||||||
| 06/15/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $12,701.00 | General |
| Category: Genetic Disease | ||||||
| 06/15/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $787.25 | General |
| Category: Genetic Disease | ||||||
| 05/15/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $12,701.00 | General |
| Category: Genetic Disease | ||||||
| 05/15/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $418.21 | General |
| Category: Genetic Disease | ||||||
| 05/15/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $175.48 | General |
| Category: Genetic Disease | ||||||
| 05/15/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $133.20 | General |
| Category: Genetic Disease | ||||||
| 05/15/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $32.00 | General |
| Category: Genetic Disease | ||||||
| 05/08/2024 | Boston Scientific Corporation | INGEVITY+ (Device) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Ingevity+_CRM | ||||||
| 04/12/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,908.00 | General |
| Category: Genetic Disease | ||||||
| 02/23/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $977.00 | General |
| Category: Genetic Disease | ||||||
| 12/07/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,471.00 | General |
| Category: Genetic Disease | ||||||
| 12/07/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $459.73 | General |
| Category: Genetic Disease | ||||||
| 12/07/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $419.94 | General |
| Category: Genetic Disease | ||||||
| 12/07/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $279.21 | General |
| Category: Genetic Disease | ||||||
| 12/07/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $105.36 | General |
| Category: Genetic Disease | ||||||
| 12/07/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $26.00 | General |
| Category: Genetic Disease | ||||||
| 12/07/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $8.12 | General |
| Category: Genetic Disease | ||||||
| 11/15/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,059.00 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 3,428 | 4,507 | $1.5M | $336,875 |
| 2022 | 34 | 3,335 | 4,203 | $1.3M | $321,734 |
| 2021 | 34 | 3,649 | 4,524 | $1.4M | $354,692 |
| 2020 | 34 | 3,867 | 4,835 | $1.5M | $355,672 |
Total Patients
14,279
Total Services
18,069
Medicare Billing
$1.4M
Procedure Codes
153
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 504 | 914 | $182,800 | $79,146 | 43.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 397 | 400 | $378,800 | $54,792 | 14.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 110 | 110 | $154,330 | $36,499 | 23.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 63 | 89 | $112,869 | $32,553 | 28.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 133 | 135 | $164,565 | $25,132 | 15.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 113 | 223 | $16,725 | $13,176 | 78.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 241 | 244 | $68,564 | $12,582 | 18.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 69 | 273 | $11,723 | $8,844 | 75.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 539 | 754 | $59,566 | $7,513 | 12.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 114 | $15,390 | $6,497 | 42.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 64 | $12,672 | $5,978 | 47.2% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 36 | 36 | $34,956 | $5,972 | 17.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 117 | 118 | $43,542 | $5,638 | 12.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $14,832 | $5,402 | 36.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 37 | $14,097 | $5,038 | 35.7% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 26 | 28 | $27,972 | $4,009 | 14.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 38 | $9,804 | $3,879 | 39.6% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $16,476 | $2,874 | 17.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 45 | $6,210 | $2,748 | 44.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 20 | $5,400 | $2,742 | 50.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 179 | 198 | $30,492 | $1,915 | 6.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 31 | 31 | $7,378 | $1,808 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 12 | $2,650 | $1,348 | 50.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 20 | 21 | $2,856 | $1,332 | 46.7% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 28 | 28 | $7,476 | $1,124 | 15.0% |
About Michael Lipinski, MD, PHD
Michael Lipinski, MD, PHD is a Interventional Cardiology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1184846289.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Lipinski, MD, PHD has received a total of $252,898 in payments from pharmaceutical and medical device companies, with $46,678 received in 2024. These payments were reported across 137 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($232,769).
As a Medicare-enrolled provider, Lipinski has provided services to 14,279 Medicare beneficiaries, totaling 18,069 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Interventional Cardiology, Cardiovascular Disease
- Location Fort Myers, FL
- Active Since 05/02/2007
- Last Updated 09/26/2025
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1184846289
Products in Payments
- FABRAZYME (Biological) $112,102
- FABRAZYME (Drug) $89,301
- LUMIZYME (Drug) $15,864
- CERDELGA (Drug) $13,664
- Aggrastat (tirofiban HCl) (Drug) $594.70
- CEREZYME (Drug) $197.55
- Arcalyst (Drug) $105.44
- ENTRESTO (Drug) $91.37
- Repatha (Biological) $60.32
- WATCHMAN (Device) $60.08
- FABRY-DISEASE (Drug) $50.47
- BRILINTA (Drug) $35.73
- Diamondback Peripheral (Device) $34.45
- ELIQUIS (Drug) $23.28
- SAMSCA (Drug) $20.46
- FlexAbility Ablation Catheter (Device) $19.87
- PRALUENT (Drug) $15.00
- INGEVITY+ (Device) $13.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Fort Myers
Katie Ryder, Do, DO
Interventional Cardiology — Payments: $15,846
Interventional Cardiology $15,846
Dr. Robert Grohowski, M.d, M.D
Interventional Cardiology — Payments: $9,724
Interventional Cardiology $9,724
Ramesh Chandra, Md, MD
Interventional Cardiology — Payments: $9,004
Interventional Cardiology $9,004
Dr. Kamaldeep Singh, Do, DO
Interventional Cardiology — Payments: $8,564
Interventional Cardiology $8,564
Dr. Nemalan Selvaraj, D.o, D.O
Interventional Cardiology — Payments: $2,394
Interventional Cardiology $2,394
Dr. James Conrad, M.d, M.D
Interventional Cardiology — Payments: $1,901
Interventional Cardiology $1,901